KAILERA THERAPEUTICS INC (KLRA)
NASDAQHealth CareBiotechnologySnapshot 2026-07-07
$22.24-4.55%
Close 2026-07-07 · 1-day change
Reading KLRA? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track KLRA free→NASDAQHealth CareBiotechnologySnapshot 2026-07-07
Reading KLRA? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track KLRA free→QuarterlyIQ Insights · KLRA
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Results of Operations and Financial Condition. On May 26, 2026, Kailera Therapeutics, Inc. (the "Company") issued a press release reporting its financial results for the quarter ended March 31, 2026. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securiti…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.